Authors : B. Niharika; M. Harika; J. P. Pramod

Volume/Issue : Volume 11 - 2026, Issue 1 - January

Google Scholar : https://tinyurl.com/mv88upvm

Scribd : https://tinyurl.com/yux66dtb

DOI : https://doi.org/10.38124/ijisrt/26jan1360

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : The increasing overlap among neuroscience, physics, and emerging technologies has triggered a revolutionary multidisciplinary discipline called Clinical Neuro-Physics and Molecular Imaging Technology that aims to integrate theoretical neuro-physics with practical applications in health and learning. This new discipline emphasizes the exploration of intricate physical, electrical, and molecular processes of brain function and applies sophisticated imaging, computational, and therapeutic technologies to enhance human welfare and learning performance. By combining concepts of neuro-physics, molecular imaging, artificial intelligence (AI), and cognitive science, this discipline seeks to bring theoretic knowledge of brain dynamics to clinically and pedagogically informed interventions that are specific, adaptive, and personalized. The present article looks at how five main areas—Neuroeducation and Cognitive Enhancement, Multimodal Neuroimaging and Real-Time Monitoring, Artificial Intelligence (AI) and Machine Learning in Neuroscience, Personalized Precision Medicine and Neurotherapeutics, and Brain- Computer Interfaces (BCIs) and Neurotechnology Integration—simultaneously define the present state and future of Clinical Neuro-Physics. Through a thorough review of existing literature, the article demonstrates how technologies in these areas are influencing paradigm shifts in diagnosis, treatment, rehabilitation and education by providing new understandings of brain structure and function. For example, multimodal imaging with functional MRI (fMRI), PET, EEG and MEG are all techniques that have proximate views of the real-time activity of the brain, providing insights into cognitive processes as well as neurological disorders. These imaging methods, combined with neuro-physics modeling, provide prediction of simulated. This research paper explores artificial intelligence (AI) and machine learning (ML) as a powerful tool to evaluate and analyze massive datasets made from neuro-imaging and molecular experiments. AI algorithms improve the processes of detecting anomalies related to brain functioning, predicting disease progression, and developing personalized clinical treatment guides. In targeted settings of education, AI is sampled into neuro-monitoring systems to personalize the learning experience, measure attention, and promote retention. The studies offered in the literature present a very accurate and flexible picture of what happens in the brain A key topic covered is personalized precision medicine that includes the usage of imaging biomarkers and neuro-physics models to detect interventions personalized to patients with neurological and psychiatric conditions. Precision-based strategies promote clinical outcomes, reduce adverse effects, and enable continuous assessment results through real-time imaging techniques. The convergence of neuroimaging, AI, and neuro- physics inclusively incorporate adaptive, patient specific sustainable neurotherapeutics arising from a patient’s neural and molecular signature. The trajectory of these advances also includes Brain Computer Interfaces (BCIs), which are capable of translating brain signals to commands to the computer - a potential for new means of motor rehabilitation, assistive communication and enhancing cognition. These interfaces exemplifies the rapid advance in the application of neuro-physics, AI and imaging technology to improve performance and accessibility. The interdisciplinary perspective presents a hopeful outlook for neuroscience's future—one in which there is less distinction between clinical practice, technological change, and intellectual learning. The unification of principles of neuro-physics with molecular imaging and intelligent computational systems is a striking illustration of how new technologies can advance human

Keywords : Artificial intelligence, Clinical neuro-physics, CT (Computed Tomography), Distance education, Ethnology, Healthcare simulation, Molecular imaging, MRI (Magnetic Resonance Imaging), Nanotoxicology, PET (Positron Emission Tomography), SPECT (Single-Photon Emission Computed Tomography).

References :

1. Molecular Neuroimaging: The Basics - PMC https://share.google/oGnwwy20bryk2rEfd.
2. Klunk WE, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Annals of neurology. 2004;55(3):306–19. doi: 10.1002/ana.20009. [DOI] [PubMed] [Google Scholar]
3. Fowler JS, et al. Synthesis and preliminary evaluation in animals of carrier-free 11C-1-dopamine hydrochloride: X. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 1973;14(11):867–9. [PubMed] [Google Scholar]
4. Moerlein SM, et al. Evaluation of 75Br-labelled butyrophenone neuroleptics for imaging cerebral dopaminergic receptor areas using positron emission tomography. European journal of nuclear medicine. 1986;12(4):211–6. doi: 10.1007/BF00256924. [DOI] [PubMed] [Google Scholar]
5. Wagner HN, Jr, et al. Imaging dopamine receptors in the human brain by positron tomography. Science. 1983;221(4617):1264–6. doi: 10.1126/science.6604315. [DOI] [PubMed] [Google Scholar]
6. Inoue Y, et al. Atlas of dopamine receptor images (PET) of the human brain. Journal of computer assisted tomography. 1985;9(1):129–40. doi: 10.1097/00004728-198501000-00024. [DOI] [PubMed] [Google Scholar]
7. Heiss WD, Herholz K. Brain receptor imaging. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2006;47(2):302–12. [PubMed] [Google Scholar]
8. Cumming P, et al. The competition between endogenous dopamine and radioligands for specific binding to dopamine receptors. Annals of the New York Academy of Sciences. 2002;965:440–50. doi: 10.1111/j.1749-6632.2002.tb04185.x. [DOI] [PubMed] [Google Scholar]
9. Elsinga PH, Hatano K, Ishiwata K. PET tracers for imaging of the dopaminergic system. Current medicinal chemistry. 2006;13(18):2139–53. doi: 10.2174/092986706777935258. [DOI] [PubMed] [Google Scholar]
10. Volkow ND, et al. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature. 1997;386(6627):830–3. doi: 10.1038/386830a0. [DOI] [PubMed] [Google Scholar]
11. Reiman EM, Jagust WJ. Brain imaging in the study of Alzheimer’s disease. NeuroImage. 2012;61(2):505–16. doi: 10.1016/j.neuroimage.2011.11.075. [DOI] [PMC free article] [PubMed] [Google Scholar]
12. Sokoloff L, et al. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. Journal of neurochemistry. 1977;28(5):897–916. doi: 10.1111/j.1471- 4159.1977.tb10649.x. [DOI] [PubMed] [Google Scholar]
13. Reivich M, et al. Measurement of local cerebral glucose metabolism in man with 18F-2-fluoro-2-deoxy-d-glucose. Acta neurologica Scandinavica Supplementum. 1977;64:190–1. [PubMed] [Google Scholar]
14. [14].Pellerin L, et al. Activity-dependent regulation of energy metabolism by astrocytes: an update. Glia. 2007;55(12):1251–62. doi: 10.1002/glia.20528. [DOI] [PubMed] [Google Scholar]
15. Ishii K. Clinical application of positron emission tomography for diagnosis of dementia. Annals of nuclear medicine. 2002;16(8):515–25. doi: 10.1007/BF02988628. [DOI] [PubMed] [Google Scholar]
16. Ishii K, et al. Cerebral glucose metabolism in patients with frontotemporal dementia. Journal of nuclear medicine: official publication, Society of Nuclear Medicine. 1998;39(11):1875–8. [PubMed] [Google Scholar]
17. Weissleder R, et al. Magnetically labeled cells can be detected by MR imaging. Journal of magnetic resonance imaging: JMRI.1997;7(1):258–63. doi: 10.1002/jmri.1880070140. [DOI] [PubMed] [Google Scholar]
18. Lewin M, et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nature biotechnology. 2000;18(4):410–4. doi: 10.1038/74464. [DOI] [PubMed] [Google Scholar]
19. Zhu J, Zhou L, XingWu F. Tracking neural stem cells in patients with brain trauma. The New England journal of medicine. 2006;355(22):2376–8. doi: 10.1056/NEJMc055304. [DOI] [PubMed] [Google Scholar]
20. Frank JA, et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology. 2003;228(2):480–7. doi: 10.1148/radiol.2281020638. [DOI] [PubMed] [Google Scholar]